Man Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-600
Closed -$243K 2469
2025
Q2
$243K Sell
600
-12,400
-95% -$5.18M ﹤0.01% 2013
2025
Q1
$6.47M Sell
13,000
-16,100
-55% -$8.72M 0.02% 913
2024
Q4
$15.1M Buy
29,100
+14,300
+97% +$7.86M 0.04% 553
2024
Q3
$9.15M Buy
14,800
+4,600
+45% +$2.72M 0.02% 787
2024
Q2
$5.64M Buy
10,200
+7,400
+264% +$4.24M 0.01% 959
2024
Q1
$1.63M Sell
2,800
-1,500
-35% -$842K ﹤0.01% 1385
2023
Q4
$2.28M Buy
+4,300
New +$2.08M 0.01% 1239

Other funds holding TMO

Man Group's TMO Position: Q2 2026 in Review

Man Group increased its Thermo Fisher Scientific (TMO) stake by 321% in Q2 2026, buying an estimated $71.4M and bringing the position to 195,160 shares worth $97.8M. The position accounts for 0.16% of the portfolio, ranked #156.

Man Group first reported a position in TMO in Q1 2018 and has held it in 31 quarters since. The position peaked at $132M in Q3 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Man Group held 195,160 shares of Thermo Fisher Scientific worth $97.8M as of Q2 2026.
  • Man Group bought 148,758 Thermo Fisher Scientific shares in Q2 2026, an estimated $71.4M.
  • Thermo Fisher Scientific made up 0.16% of Man Group's portfolio in Q2 2026, its #156 holding.
  • Man Group first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 31 quarters since.
  • Man Group's Thermo Fisher Scientific position peaked at $132M in Q3 2021.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.